Up to $150,000,000Sales Agreement • April 14th, 2025
This summary highlights selected information that is presented in greater detail elsewhere, or incorporated by reference, in this prospectus. It does not contain all of the information that may be important to you and your investment decision. Before investing in our securities, you should carefully read this entire prospectus, including the matters set forth in the section titled “Risk Factors” and the financial statements and related notes and other information that we incorporate by reference herein, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Unless the context indicates otherwise, references in this prospectus to “LENZ Therapeutics, Inc.,” “we,” “our” and “us” refer, collectively, to LENZ Therapeutics, Inc., a Delaware corporation and its subsidiaries taken as a whole.